180 related articles for article (PubMed ID: 38530453)
1. Multisystem inflammatory syndrome in children: an Umbrella review.
Shioji N; Sumie M; Englesakis M; Gilfoyle E; Maynes JT; Aoyama K
J Anesth; 2024 Jun; 38(3):309-320. PubMed ID: 38530453
[TBL] [Abstract][Full Text] [Related]
2. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal Membrane Oxygenation for COVID-19-Associated Multisystem Inflammatory Syndrome in a 5-year-old.
Schwartz SP; Walker TC; Kihlstrom M; Isani M; Smith MM; Smith RL; McLean SE; Clement KC; Phillips MR
Am Surg; 2022 Feb; 88(2):174-176. PubMed ID: 33372818
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Multisystem Inflammatory Syndrome in Children.
McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M;
N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854
[TBL] [Abstract][Full Text] [Related]
5. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
[TBL] [Abstract][Full Text] [Related]
6. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
7. Multisystem Inflammatory Syndrome in Children (MIS-C).
Patel JM
Curr Allergy Asthma Rep; 2022 May; 22(5):53-60. PubMed ID: 35314921
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
9. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City.
Kaushik S; Aydin SI; Derespina KR; Bansal PB; Kowalsky S; Trachtman R; Gillen JK; Perez MM; Soshnick SH; Conway EE; Bercow A; Seiden HS; Pass RH; Ushay HM; Ofori-Amanfo G; Medar SS
J Pediatr; 2020 Sep; 224():24-29. PubMed ID: 32553861
[TBL] [Abstract][Full Text] [Related]
10. Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India.
Angurana SK; Kumar V; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M
J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36048462
[TBL] [Abstract][Full Text] [Related]
11. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.
Martin B; DeWitt PE; Russell S; Anand A; Bradwell KR; Bremer C; Gabriel D; Girvin AT; Hajagos JG; McMurry JA; Neumann AJ; Pfaff ER; Walden A; Wooldridge JT; Yoo YJ; Saltz J; Gersing KR; Chute CG; Haendel MA; Moffitt R; Bennett TD
JAMA Netw Open; 2022 Feb; 5(2):e2143151. PubMed ID: 35133437
[TBL] [Abstract][Full Text] [Related]
12. Treatment of multisystem inflammatory syndrome in children.
Tong T; Jin YH; Wang M; Gong FQ
World J Pediatr; 2024 Apr; 20(4):325-339. PubMed ID: 38509432
[TBL] [Abstract][Full Text] [Related]
13. New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults.
Chen CJ; Kao HY; Huang CH; Li CJ; Hung CH; Yong SB
Ital J Pediatr; 2024 Jan; 50(1):18. PubMed ID: 38273368
[TBL] [Abstract][Full Text] [Related]
14. Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review.
Wang Z; Zhao S; Tang Y; Wang Z; Shi Q; Dang X; Gan L; Peng S; Li W; Zhou Q; Li Q; Mafiana JJ; Cortés RG; Luo Z; Liu E; Chen Y
Eur J Pediatr; 2022 May; 181(5):2135-2146. PubMed ID: 35192051
[TBL] [Abstract][Full Text] [Related]
15. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.
Abrams JY; Oster ME; Godfred-Cato SE; Bryant B; Datta SD; Campbell AP; Leung JW; Tsang CA; Pierce TJ; Kennedy JL; Hammett TA; Belay ED
Lancet Child Adolesc Health; 2021 May; 5(5):323-331. PubMed ID: 33711293
[TBL] [Abstract][Full Text] [Related]
16. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
Pereira MFB; Litvinov N; Farhat SCL; Eisencraft AP; Gibelli MABC; Carvalho WB; Fernandes VR; Fink TT; Framil JVS; Galleti KV; Fante AL; Fonseca MFM; Watanabe A; Paula CSY; Palandri GG; Leal GN; Diniz MFR; Pinho JRR; Silva CA; Marques HHS; ; Rossi Junior A; Delgado AF; Andrade APM; Schvartsman C; Sabino EC; Rocha MC; Kanunfre KA; Okay TS; Carneiro-Sampaio MMS; Jorge PPD
Clinics (Sao Paulo); 2020; 75():e2209. PubMed ID: 32844958
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.
Swann OV; Holden KA; Turtle L; Pollock L; Fairfield CJ; Drake TM; Seth S; Egan C; Hardwick HE; Halpin S; Girvan M; Donohue C; Pritchard M; Patel LB; Ladhani S; Sigfrid L; Sinha IP; Olliaro PL; Nguyen-Van-Tam JS; Horby PW; Merson L; Carson G; Dunning J; Openshaw PJM; Baillie JK; Harrison EM; Docherty AB; Semple MG;
BMJ; 2020 Aug; 370():m3249. PubMed ID: 32960186
[TBL] [Abstract][Full Text] [Related]
18. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.
Mohsin SS; Abbas Q; Chowdhary D; Khalid F; Sheikh AS; Ali Khan ZG; Aslam N; Bhatti OA; Inam M; Saleem AF; Bhutta AT
PLoS One; 2021; 16(6):e0253625. PubMed ID: 34153080
[TBL] [Abstract][Full Text] [Related]
19. Severe Multi-inflammatory Syndrome in Children Temporally Related to COVID 19-Clinical Course, Laboratory Profile and Outcomes from a North Indian PICU.
Chattopadhyay A; Saigal Kalra K; Saikia D; Yadav V; Chouksey J; Jajoo M; Sherwal BL
J Intensive Care Med; 2022 Sep; 37(9):1229-1237. PubMed ID: 35469487
[No Abstract] [Full Text] [Related]
20. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
